Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP-1 (MCAF) | 2046.0 | 83 | |
| RA2159 | PI103 | 0.1 | uM | 1 | MCP-1 (MCAF) | 3448.0 | 82 | ||||
| N2586 | IL-1 alpha | 100 | ng/mL | 1 | MCP-1 (MCAF) | 15490.0 | 71 | ||||
| N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP-1 (MCAF) | 14669.0 | 83 | |
| N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP-1 (MCAF) | 14300.5 | 62 | |
| N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP-1 (MCAF) | 14427.0 | 60 | |
| N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP-1 (MCAF) | 15263.0 | 71 | |
| N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MCP-1 (MCAF) | 9911.0 | 54 | |
| N2586 | PI103 | 0.1 | uM | 1 | MCP-1 (MCAF) | 6772.5 | 58 | ||||
| RA2159 | IL-6 | 100 | ug/mL | 1 | MCP-1 (MCAF) | 3014.0 | 73 | ||||
| RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | MCP-1 (MCAF) | 1688.0 | 102 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MCP-1 (MCAF) | 1963.0 | 81 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MCP-1 (MCAF) | 2894.5 | 92 | |
| RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MCP-1 (MCAF) | 2868.0 | 77 | |
| RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | MCP-1 (MCAF) | 1529.0 | 64 | |
| RA2159 | Sigma A6730 | 3.0 | uM | 1 | MCP-1 (MCAF) | 2291.5 | 80 | ||||
| N2586 | IL-6 | 100 | ug/mL | 1 | MCP-1 (MCAF) | 7935.0 | 68 | ||||
| N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | MCP-1 (MCAF) | 5279.0 | 57 | |
| N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MCP-1 (MCAF) | 4718.0 | 59 | |
| N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MCP-1 (MCAF) | 6953.5 | 52 | |
| N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MCP-1 (MCAF) | 5986.0 | 59 | |
| N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | MCP-1 (MCAF) | 6395.0 | 82 | |
| N2586 | Sigma A6730 | 3.0 | uM | 1 | MCP-1 (MCAF) | 7604.0 | 54 | ||||
| RA2159 | IL-17A | 100 | ng/mL | 1 | MCP-1 (MCAF) | 3816.0 | 76 | ||||
| RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | MCP-1 (MCAF) | 1856.5 | 70 |